...

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Shortened-Duration Tacrolimus after Nonmyeloablative HLA-Haploidentical (NMA haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Facilitates Strategies for Relapse Reduction

【24h】

Shortened-Duration Tacrolimus after Nonmyeloablative HLA-Haploidentical (NMA haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Facilitates Strategies for Relapse Reduction

机译：非清髓性HLA单倍型（NMA haplo）BMT与大剂量移植后环磷酰胺（PTCy）联合应用后，他克莫司的持续时间缩短，有助于减少复发的策略

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共5页
作者
Kasamon Yvette L.; Fuchs Ephraim J.; Zahurak Marianna; Rosner Gary L.; Symons Heather J.; Bolanos-Meade Javier; Jones Richard J.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献

1. Shortened-Duration Tacrolimus after Nonmyeloablative HLA-Haploidentical (NMA haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Facilitates Strategies for Relapse Reduction [J] . Kasamon Yvette L., Fuchs Ephraim J., Zahurak Marianna, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：非清髓性HLA单倍型（NMA haplo）BMT与大剂量移植后环磷酰胺（PTCy）联合应用后，他克莫司的持续时间缩短，有助于减少复发的策略
2. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide [J] . McCurdy Shannon R., Kanakry Jennifer A., Showel Margaret M., Blood: The Journal of the American Society of Hematology . 2015,第19期

机译：高剂量移植后环磷酰胺治疗非清髓性HLA单倍型BMT的风险分层结果
3. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. [J] . Kasamon YL, Luznik L, Leffell MS, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2010,第4期

机译：非清髓性HLA单倍体骨髓移植与大剂量移植后环磷酰胺：HLA差异对预后的影响。
4. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide [O] . Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel, -1

机译：大剂量移植后环磷酰胺治疗非清髓性HLA单倍型BMT的风险分层结果
5. Significance of Haplotype B Donors and Gene Content Motifs in Nonmyeloablative, HLA-Haploidentical (Haplo) Bmt with Posttransplantation High-Dose Cyclophosphamide (PT/Cy) [O] . Symons H.J., Munchel A.T., Rossiter N.L., 2012

机译：移植后大剂量环磷酰胺（PT / Cy）的非清髓性HLA单倍型（Haplo）Bmt中单倍型B供体和基因含量基序的意义

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号